Alantolactone Inhibits Double Expression Lymphoma via Dual-Targeted Glycogen Synthase Kinase 3 Beta and B-Cell Lymphoma2Jianhua Chen, Zhengmin Xu|Blood and Lymphatic Cancer Targets and Therapy|2025Cited by 0